Advanced Biomed ADVB
NASDAQ ADVB
$6.23 -0.09 (-1.42%)
At close: Sep 30, 2026 · 4:00 PM EDT

Advanced Biomed (ADVB) Other Non-Current Liabilities (2025)

Updated

Advanced Biomed (ADVB) recorded Other Non-Current Liabilities of $114,065 in fiscal Q2 2026 (quarter ended Dec 31, 2025), down 40.3% from the prior quarter.

Analysis

Advanced Biomed (ADVB) Other Non-Current Liabilities (2025) Analysis & Trends

At the end of FY2025 (ended Jun 30, 2025), Advanced Biomed reported Other Non-Current Liabilities of $69,975.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Advanced Biomed 8.61 Mn 8.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 114,065.00
Sep 30, 2025 190,959.00
Jun 30, 2025 69,975.00
API Access

Advanced Biomed Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ADVB&period=max&api_key=YOUR_API_KEY